Condition
Breast Reconstruction With Silicone Implants
Total Trials
3
Recruiting
2
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
Trial Status
Recruiting2
Completed1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT07679594Recruiting
A Post-market Prospective Clinical Study of Eurosilicone Luna Mammary Implants
NCT06013514Recruiting
Post-market Prospective Clinical Study of Nagor Perle Mammary Implants
NCT00581984CompletedPrimary
McGhan Medical Silicone-Filled Breast Implant Adjunct Study
Showing all 3 trials